BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19009369)

  • 1. Diagnostic value of prostate-specific antigen (PSA) and free prostate specific antigen (fPSA) in women with ovulatory and anovulatory polycystic ovary syndrome.
    UKINC K; Ersoz HO; Erem C; Hacihasanoglu AB
    Endocrine; 2009 Feb; 35(1):123-9. PubMed ID: 19009369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of ovarian volume and outline has better diagnostic accuracy than prostate-specific antigen (PSA) concentrations in women with polycystic ovarian syndrome (PCOs).
    Bili E; Dampala K; Iakovou I; Tsolakidis D; Giannakou A; Tarlatzis BC
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():32-5. PubMed ID: 24965976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum complexed and free prostate-specific antigen (PSA) for the diagnosis of the polycystic ovarian syndrome (PCOS).
    Diamandis EP; Stanczyk FZ; Wheeler S; Mathew A; Stengelin M; Nikolenko G; Glezer EN; Brown MD; Zheng Y; Chen YH; Wu HL; Azziz R
    Clin Chem Lab Med; 2017 Oct; 55(11):1789-1797. PubMed ID: 28361781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of prostatic specific antigen in hirsute women.
    Güllü S; Emral R; Asik M; Cesur M; Tonyukuk V
    J Endocrinol Invest; 2003 Dec; 26(12):1198-202. PubMed ID: 15055472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome - a new insight.
    Rudnicka E; Radowicki S; Suchta K
    Gynecol Endocrinol; 2016 Nov; 32(11):931-935. PubMed ID: 27426018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does ovarian blood flow distinguish between ovulatory and anovulatory patients with polycystic ovary syndrome?
    Carmina E; Longo A; Lobo RA
    Am J Obstet Gynecol; 2003 Nov; 189(5):1283-6. PubMed ID: 14634554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Prostate-Specific Antigen Level in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis.
    Maleki-Hajiagha A; Razavi M; Rezaeinejad M; Sepidarkish M; Mehri A; Vesali S; Allameh Z
    Horm Metab Res; 2019 Apr; 51(4):230-242. PubMed ID: 31022739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of prostate-specific antigen in women with polycystic ovary syndrome.
    Mardanian F; Heidari N
    J Res Med Sci; 2011 Aug; 16(8):999-1005. PubMed ID: 22279474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome.
    Carmina E; Bucchieri S; Mansueto P; Rini G; Ferin M; Lobo RA
    Fertil Steril; 2009 Apr; 91(4 Suppl):1332-5. PubMed ID: 18455165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostatic-specific antigen (PSA) levels in patients with polycystic ovary syndrome (PCOS): a meta-analysis.
    Wu ZH; Tang Y; Niu X; Pu FF; Xiao XY; Kong W
    J Ovarian Res; 2019 Oct; 12(1):94. PubMed ID: 31615559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Value of Prostate-Specific Antigen in Diagnosis of Polycystic Ovarian Syndrome in Adolescent Girls.
    Tokmak A; Bodur S; Erkilinc S; Ozel S; Engin-Ustun Y
    J Pediatr Adolesc Gynecol; 2018 Jun; 31(3):263-269. PubMed ID: 29162532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Piouka A; Livadas S; Piperi C; Katsikis I; Papavassiliou AG; Panidis D
    Eur J Endocrinol; 2009 May; 160(5):847-53. PubMed ID: 19208775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance variability in women with anovulatory and ovulatory polycystic ovary syndrome, and normal controls.
    Cho LW; Kilpatrick ES; Keevil BG; Jayagopal V; Coady AM; Rigby AS; Atkin SL
    Horm Metab Res; 2011 Feb; 43(2):141-5. PubMed ID: 21234853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
    Vural B; Ozkan S; Bodur H
    J Obstet Gynaecol Res; 2007 Apr; 33(2):166-73. PubMed ID: 17441890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide+desogestrel/ethinyl estradiol combination.
    Bahceci M; Bilge M; Tuzcu A; Tuzcu S; Bahceci S
    J Endocrinol Invest; 2004 Apr; 27(4):353-6. PubMed ID: 15233555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome.
    Romero-Ruiz A; Skorupskaite K; Gaytan F; Torres E; Perdices-Lopez C; Mannaerts BM; Qi S; Leon S; Manfredi-Lozano M; Lopez-Rodriguez C; Avendaño MS; Sanchez-Garrido MA; Vazquez MJ; Pinilla L; van Duin M; Kohout TA; Anderson RA; Tena-Sempere M
    Hum Reprod; 2019 Dec; 34(12):2495-2512. PubMed ID: 31820802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
    Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of percent free prostate-specific antigen measurement on improving the specificity of serum prostate-specific antigen testing in Taiwanese patients.
    Liao CH; Liu SP; Pu YS; Huang CY; Yu HJ; Chen J
    J Formos Med Assoc; 2001 Feb; 100(2):113-9. PubMed ID: 11393098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.